Visterra Raises $6 Million
Visterra Inc., a Camrbidge, Mass.-based developer of technologies that can interrogate how pathogens interact with human cells, has raised $6 million in first-round funding. Backers include Flagship Ventures, Lux Capital and Polaris Venture Partners. The company is an MIT spinout, and previously was called Parasol Therapeutics.
9 July 2010•7 mins read
